NYSE
DHR

Danaher Corporation

Diagnostics & Research
Healthcare

Prices are adjusted according to historical splits.

Danaher Corporation Stock Price

Vitals

Today's Low:
$245.5
Today's High:
$250.32
Open Price:
$249.45
52W Low:
$221.22
52W High:
$302.9113
Prev. Close:
$250.17
Volume:
2374709

Company Statistics

Market Cap.:
$172.02 billion
Book Value:
68.308
Revenue TTM:
$30.95 billion
Operating Margin TTM:
27.02%
Gross Profit TTM:
$18.95 billion
Profit Margin:
22.4%
Return on Assets TTM:
6.21%
Return on Equity TTM:
14.17%

Company Profile

Danaher Corporation had its IPO on 1979-01-05 under the ticker symbol DHR.

The company operates in the Healthcare sector and Diagnostics & Research industry. Danaher Corporation has a staff strength of 79,000 employees.

Stock update

Shares of Danaher Corporation opened at $249.45 at the start of the last trading session i.e. 2023-09-12.

The stocks traded within a range of $245.5 - $250.32, and closed at $248.33.

This is a -0.74% slip from the previous day's closing price.

A total volume of 2,374,709 shares were traded at the close of the day’s session.

In the last one week, shares of Danaher Corporation have slipped by -6.5%.

Danaher Corporation's Key Ratios

Danaher Corporation has a market cap of $172.02 billion, indicating a price to book ratio of 4.3266 and a price to sales ratio of 6.2915.

In the last 12-months Danaher Corporation’s revenue was $30.95 billion with a gross profit of $18.95 billion and an EBITDA of $10.58 billion. The EBITDA ratio measures Danaher Corporation's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Danaher Corporation’s operating margin was 27.02% while its return on assets stood at 6.21% with a return of equity of 14.17%.

In Q1, Danaher Corporation’s quarterly earnings growth was a negative -16% while revenue growth was a negative 6.8%.

Danaher Corporation’s PE and PEG Ratio

Forward PE
25.9067
Trailing PE
24.906
PEG
3.2365

Its diluted EPS in the last 12-months stands at $9.36 per share while it has a forward price to earnings multiple of 25.9067 and a PEG multiple of 3.2365. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Danaher Corporation’s profitability.

Danaher Corporation stock is trading at a EV to sales ratio of 6.7787 and a EV to EBITDA ratio of 19.9261. Its price to sales ratio in the trailing 12-months stood at 6.2915.

Danaher Corporation stock pays annual dividends of $1.02 per share, indicating a yield of 0.46% and a payout ratio of 9.86%.

Balance sheet and cash flow metrics

Total Assets
$85.04 billion
Total Liabilities
$8.73 billion
Operating Cash Flow
$-304000000.00
Capital Expenditure
$275 million
Dividend Payout Ratio
9.86%

Danaher Corporation ended 2024 with $85.04 billion in total assets and $0 in total liabilities. Its intangible assets were valued at $85.04 billion while shareholder equity stood at $51.48 billion.

Danaher Corporation ended 2024 with $0 in deferred long-term liabilities, $8.73 billion in other current liabilities, 9000000.00 in common stock, $40.44 billion in retained earnings and $39.86 billion in goodwill. Its cash balance stood at $7.38 billion and cash and short-term investments were $7.38 billion. The company’s total short-term debt was $1,571,000,000 while long-term debt stood at $18.26 billion.

Danaher Corporation’s total current assets stands at $16.53 billion while long-term investments were $0 and short-term investments were $0. Its net receivables were $4.31 billion compared to accounts payable of $2.08 billion and inventory worth $3.38 billion.

In 2024, Danaher Corporation's operating cash flow was $-304000000.00 while its capital expenditure stood at $275 million.

Comparatively, Danaher Corporation paid $0.10 in dividends in 2024.

Other key metrics

Current Trading Price
$248.33
52-Week High
$302.9113
52-Week Low
$221.22
Analyst Target Price
$278.71

Danaher Corporation stock is currently trading at $248.33 per share. It touched a 52-week high of $302.9113 and a 52-week low of $302.9113. Analysts tracking the stock have a 12-month average target price of $278.71.

Its 50-day moving average was $251.69 and 200-day moving average was $250.72 The short ratio stood at 1.07 indicating a short percent outstanding of 0%.

Around 1077.2% of the company’s stock are held by insiders while 7969.6% are held by institutions.

Frequently Asked Questions About Danaher Corporation

The stock symbol (also called stock or share ticker) of Danaher Corporation is DHR

The IPO of Danaher Corporation took place on 1979-01-05

Similar Industry Stocks (Diagnostics & Research)

Last Price
Chg
Chg%
$10.43
0.09
+0.92%
$280.71
0.95
+0.34%
$19.33
0.03
+0.16%
$0.11
-0.01
-4.55%
$60.97
-1.22
-1.96%
$21.67
-0.03
-0.14%
$30
-0.5
-1.64%
$1352.21
25.32
+1.91%
$0.04
0.01
+36.56%
$28.76
0.01
+0.03%

Most Active

Last Price
Chg
Chg%
Amyris Inc (AMRS)
$0.14
0.07
+100%
$0.12
0.04
+45.29%
$0.96
0.05
+5.4%
$1.34
-0.35
-20.71%
Humbl Inc (HMBL)
$0
0
0%

Top Gainers

Last Price
Chg
Chg%
$0
0
+172200%
$0
0
+51200%
$283
280.03
+9428.62%
$11.2
10.57
+1667.68%
Latch Inc (LTCHW)
$0.01
-0.03
+1550%

Top Losers

Last Price
Chg
Chg%
$0.19
-123.15
-99.85%
$0
-0.11
-99.55%
$0
-0
-97.96%
$0
-0.01
-93.94%
$0.01
-0.06
-92.24%

About

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes and services; and healthcare filtration solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automation, centrifugation, particle counting and characterization; microscopes; genomics consumables; and Gene and Cell Therapy to the pharmaceutical and biopharmaceutical, food and beverage, medical, and life sciences companies, as well as universities, medical schools and research institutions, and various industrial manufacturers. The Diagnostics segment provides chemistry, immunoassay, microbiology, and automation systems, as well as hematology, molecular, acute care, and pathology diagnostics products. This segment offers clinical instruments, reagents, consumables, software, and services for hospitals, physicians’ offices, reference laboratories, and other critical care settings. The Environmental & Applied Solutions segment offers instrumentation, consumables, software, services, and disinfection systems to analyze, treat, and manage ultra-pure, potable, industrial, waste, ground, source, and ocean water in residential, commercial, municipal, industrial, and natural resource applications. It also provides instruments, software, services, and consumables for various color and appearance management, packaging design and quality management, packaging converting, printing, marking, coding, and traceability applications for consumer, pharmaceutical, and industrial products. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. The company was founded in 1969 and is headquartered in Washington, the District of Columbia.

Address

2200 Pennsylvania Avenue, NW, Washington, DC, United States, 20037-1701